Data protection Impressum

Digital Health

MoleSense and Impli, both based at the Biopôle life sciences campus, have been selected by Germany's Federal Agency for Breakthrough Innovation to develop biosensors capable of continuously measuring at least four hormones over seven days.

MoleSense and Impli selected for the SPRIND Challenge on continuous hormone monitoring

3 August 2026

Carewell, a Lausanne-based start-up whose platform helps Swiss healthcare institutions manage staff shortages, has raised CHF 1.5 million in a seed round to accelerate its expansion across Switzerland.

Carewell raises CHF 1.5 million to manage healthcare staff shortages

6 July 2026

Top Stories Western Switzerland

Top Stories from Western Switzerland (June 2026)

29 June 2026

Geneva-based medtech company ABCDx has reached several milestones with LVOCheck, its point-of-care platform for diagnosing large vessel occlusion stroke, including a peer-reviewed publication, the completion of a Eurostars project and the start of its industrialization.

Geneva’s ABCDx reaches several milestones with its acute stroke diagnostics platform

29 June 2026

LEM Surgical, a Bern-based developer of robotic technologies for hard tissue surgery, has received a second FDA 510(k) clearance for its Dynamis Robotic Surgical System, adding new capabilities for spine surgery.

Bern-based LEM Surgical secures second FDA clearance for its Dynamis surgical robot

24 June 2026

The Foundation for Innovation and Technology has awarded CHF 100,000 Tech Seed loans to Detectra, TUUS Solutions and Anyway Systems, supporting innovations in arthritis monitoring, nutrient delivery and sovereign AI infrastructure.

FIT grants Tech Seed loans to three innovative Vaud start-ups

22 June 2026

SOPHiA GENETICS, the Lausanne-based leader in AI-driven precision medicine, has closed an oversubscribed public offering with gross proceeds of USD 57.5 million to expand its platform, applications and partnerships.

SOPHiA GENETICS raises USD 57.5 million in oversubscribed public offering

22 June 2026

Impli, the deeptech company developing continuous molecular monitoring for hormonal health and present at Biopôle in Lausanne, has been awarded a GBP 1.4 million grant to bring its hormone-monitoring patch toward clinical validation for in vitro fertilization.

Impli secures GBP 1.4 million grant to advance continuous hormone monitoring for IVF

16 June 2026

Geneva-based femtech start-up TrialHer has converted early demand into paid pilots with two companies in the UK and Europe, and was selected to join the WHO/Europe Public Health Innovation Platform.

Geneva femtech TrialHer secures first paid pilots and WHO selection

15 June 2026

Geneva-based MindMaze Therapeutics announced a CHF 8 million strategic equity financing from Neuro.io Group, funding the expansion of its U.S. commercial operations and opening the door to a potential combination of neurotherapeutics and artificial intelligence.

MindMaze secures CHF 8 million to expand its neurotherapeutics platform

1 June 2026

1 2 3 4 5 6 … 14